Literature DB >> 1506999

Marijuana and immunity.

L E Hollister1.   

Abstract

Despite the fairly large literature that developed during the past 15 years or so, the effect of cannabinoids on the immune system is still unsettled. The evidence has been contradictory and is more supportive of some degree of immunosuppression only when one considers in vitro studies. These have been seriously flawed by the very high concentrations of drug used to produce immunosuppression and by the lack of comparisons with other membrane-active drugs. The closer that experimental studies have been to actual clinical situations, the less compelling has been the evidence. Although the topic was of great interest during the 1970's, as indicated by the preponderance of the references from that period, interest has waned during the present decade. This waning of interest suggests that perhaps most investigators feel that this line of inquiry will not be rewarding. The AIDS epidemic has also diverted the attention of immunologists to the far more serious problem of the truly devastating effects a retrovirus can have on a portion of the immune system. The relationship between the use of social drugs and the development of clinical manifestations of AIDS has been of some interest, however. Persons infected with the virus but not diagnosed as AIDS have been told to avoid the use of marijuana and/or alcohol. This advice may be reasonable as a general health measure, but direct evidence that heeding this warning will prevent the ultimate damage to the immune system is totally lacking.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1506999     DOI: 10.1080/02791072.1992.10471635

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  6 in total

Review 1.  Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.

Authors:  William E Greineisen; Helen Turner
Journal:  Int Immunopharmacol       Date:  2010-02-25       Impact factor: 4.932

2.  Marijuana use and mortality.

Authors:  S Sidney; J E Beck; I S Tekawa; C P Quesenberry; G D Friedman
Journal:  Am J Public Health       Date:  1997-04       Impact factor: 9.308

3.  Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.

Authors:  Andrea L Small-Howard; Lori M N Shimoda; Chaker N Adra; Helen Turner
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

4.  Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain.

Authors:  Nancy L Sohler; Joanna L Starrels; Laila Khalid; Marcus A Bachhuber; Julia H Arnsten; Shadi Nahvi; John Jost; Chinazo O Cunningham
Journal:  Subst Use Misuse       Date:  2018-01-17       Impact factor: 2.164

5.  Medical Marijuana and Opioids (MEMO) Study: protocol of a longitudinal cohort study to examine if medical cannabis reduces opioid use among adults with chronic pain.

Authors:  Chinazo O Cunningham; Joanna L Starrels; Chenshu Zhang; Marcus A Bachhuber; Nancy L Sohler; Frances R Levin; Haruka Minami; Deepika E Slawek; Julia H Arnsten
Journal:  BMJ Open       Date:  2020-12-29       Impact factor: 2.692

Review 6.  The Link between Cannabis Use, Immune System, and Viral Infections.

Authors:  Sanjay B Maggirwar; Jag H Khalsa
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.